Home/ Supplements/ Boswellia/ Maxi Boz II

Maxi Boz II

product on market Capsule AOR Advanced Orthomolecular Research Premium Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Boswellia is supported by moderate evidence for its ability to reduce inflammation and support joint health. Research indicates it may inhibit pro-inflammatory enzymes to alleviate discomfort. The overall evidence coverage for this specific formulation remains limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Maxi Boz II
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
90
Servings
Botanical
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

1000 mg
Market median: 375.0mg (171 products) 31 studies (A:1, B:14)

Other Ingredients

Microcrystalline Cellulose Potato Starch Capsule Sodium Stearyl Fumarate
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: Take 1 capsule 1-3 times daily with food, or as directed by a qualified health care practitioner. Use for a minimum of 2 months to see beneficial effects.

Warnings & Precautions

Caution: Some people may experience mild gastrointestinal effects in which case, discontinue use. Consult your physician for use beyond 6 months.

Warning: Consult your physician before use if you’re pregnant, lactating, have medical condition, or if you’re taking any medication.

Keep out of reach of children.

To report a serious adverse event or obtain product information, call 1-866-215-0450

Formulation Notes

GMP Manufacturing Quality assured Independent testing

Discussion: Maxi Boz II is formulated with a standardized extract of boswellia, a botanical used in Ayurvedic medicine.

Aryuvedic support for healthy joints

Vegan

Non-GMO Gluten free

AOR guarantees that all ingredients have been declared on the label.

Made without wheat, gluten, corn, nuts, peanuts, sesame seeds, sulfites, mustard, soy, dairy, eggs, fish, shellfish or any animal byproduct.

Note: Natural herbal extracts will vary in color from one crop to another.

Additional Information

Do not use if safety seal is broken

Store tightly sealed in a cool, dry place

Product of Canada

Metadata

Product Details

UPC / SKU6 24917 08245 6
DSLD Entry Date2020-03-24
Product TypeBotanical
FormCapsule
DSLD ID214691
Data Updated2026-04-11
Research

Research Evidence

33
Research Sources
55
Avg Quality
17
Systematic Review
12
Meta Analysis
3
Rct
1
Clinical Trial
A Oral herbal therapies for treating osteoarthritis
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
B Interventions for treating collagenous colitis
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
B Efficacy of curcumin and Boswellia for knee osteoarthritis: Systematic review and meta-analysis
Meta Analysis Seminars in arthritis and rheumatism 2018 PubMed DOI
B Evaluating the efficacy and safety of Curcuma longa, Boswellia serrata, and their mixed formulation in treating knee osteoarthritis: A systematic review and network meta-analysis
Systematic Review Complementary therapies in medicine 2026 PubMed DOI
B Effectiveness of Boswellia and Boswellia extract for osteoarthritis patients: a systematic review and meta-analysis
Meta Analysis BMC complementary medicine and therapies 2020 PubMed DOI
B Effectiveness and Safety of Ayurvedic Medicines in Type 2 Diabetes Mellitus Management: A Systematic Review and Meta-Analysis
Systematic Review Frontiers in pharmacology 2022 PubMed DOI
B Interventions for treating collagenous colitis
Meta Analysis The Cochrane database of systematic reviews 2008 PubMed DOI
B Ayurvedic interventions for osteoarthritis: a systematic review and meta-analysis
Meta Analysis Rheumatology international 2015 PubMed DOI
B Oral herbal medicines marketed in Brazil for the treatment of osteoarthritis: A systematic review and meta-analysis
Meta Analysis Phytotherapy research : PTR 2017 PubMed DOI
B Frankincense: systematic review
Systematic Review BMJ (Clinical research ed.) 2008 PubMed DOI
View all evidence for Boswellia →
Compare

Similar Products

View all Boswellia products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.